Latest posts
-
AI in Pharma Market Access: Mid-2025 Update
Six months on from our 2025 outlook, AI has moved from pilot to production in market access. Investors are backing AI-enabled solutions, payers are scaling AI for member support and prior auth, regulators are enforcing the EU AI Act, and CMS is updating PE methodology. Here’s what changed and what PMA teams should do next.